Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Oncol., 11 September 2025

Sec. Cancer Immunity and Immunotherapy

Volume 15 - 2025 | https://doi.org/10.3389/fonc.2025.1694570

Correction: PNI as a predictive biomarker: a novel nomogram of immunotherapy efficacy in advanced breast cancer

This article is a correction to:

  1. PNI as a predictive biomarker: a novel nomogram of immunotherapy efficacy in advanced breast cancer

    1. Read original article
Xinyang Li,&#x;Xinyang Li1,2†Xiang Cheng&#x;Xiang Cheng2†Yikai HanYikai Han2Xiaodan LiuXiaodan Liu2Yujin FangYujin Fang2Shengju RenShengju Ren2Xiangwen DongXiangwen Dong2Ziwen LeiZiwen Lei2Yue Zhang*Yue Zhang3*Tengfei Zhang,,*Tengfei Zhang1,2,4*
  • 1The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, China
  • 2Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
  • 3Department of Oncology, Dengzhou Central Hospital, Dengzhou, Henan, China
  • 4Medical School, Huanghe Science and Technology University, Zhengzhou, Henan, China

A Correction on
PNI as a predictive biomarker: a novel nomogram of immunotherapy efficacy in advanced breast cancer

By Li X, Cheng X, Han Y, Liu X, Fang Y, Ren S, Dong X, Lei Z, Zhang Y and Zhang T (2025) Front. Oncol. 15:1534545. doi: 10.3389/fonc.2025.1534545

Affiliation “The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, China” was omitted from the paper. This affiliation has now been added for author Tengfei Zhang and Xinyang Li.

The corresponding author list appeared in the wrong order. The correct version is "Tengfei Zhang:ZmNjemhhbmd0ZkB6enUuZWR1LmNuLA== Yue Zhang:ODE0MDMxMzM5QHFxLmNvbQ==".

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: breast cancer, nomogram, prognostic nutritional index, immunotherapy, prognosis

Citation: Li X, Cheng X, Han Y, Liu X, Fang Y, Ren S, Dong X, Lei Z, Zhang Y and Zhang T (2025) Correction: PNI as a predictive biomarker: a novel nomogram of immunotherapy efficacy in advanced breast cancer. Front. Oncol. 15:1694570. doi: 10.3389/fonc.2025.1694570

Received: 28 August 2025; Accepted: 31 August 2025;
Published: 11 September 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Li, Cheng, Han, Liu, Fang, Ren, Dong, Lei, Zhang and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Tengfei Zhang, ZmNjemhhbmd0ZkB6enUuZWR1LmNu; Yue Zhang, ODE0MDMxMzM5QHFxLmNvbQ==

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.